The new risk adjustment formula in Germany: Implementation and first experiences

Health Policy

Volumn 109, Issue 3, 2013, Pages 253-262

  Buchner, Florian ^a   Goepffarth, Dirk ^b   Wasem, Juergen ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b Federal Insurance Office   (Germany)

Author keywords

Central health fund; Competition; Germany; Health insurance; Risk adjustment

Indexed keywords

ACCURACY; ARTICLE; CHRONIC DISEASE; COMPETITION; DISEASE SEVERITY; EXPERIENCE; FINANCIAL MANAGEMENT; GERMANY; HEALTH CARE PLANNING; HUMAN; MORBIDITY; PERFORMANCE; PRESCRIPTION; RISK ASSESSMENT; SOCIAL INSURANCE; VALIDITY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; ECONOMIC COMPETITION; GERMANY; GOVERNMENT REGULATION; HEALTHCARE FINANCING; HUMANS; INFANT; INSURANCE, HEALTH; MIDDLE AGED; MODELS, THEORETICAL; NATIONAL HEALTH PROGRAMS; RISK ADJUSTMENT; YOUNG ADULT;

EID: 84874341113     PISSN: 01688510     EISSN: 18726054     Source Type: Journal    
DOI: 10.1016/j.healthpol.2012.12.001     Document Type: Article

References (24)

1. Jacobs K., Reschke P., Cassel D., Wasem J. Zur Wirkung des Risikostrukturausgleichs in der gesetzlichen Krankenversicherung 2002, Schriftenreihe des Bundesministeriums für Gesundheit, Baden-Baden, Nomos.
2. Göpffarth D. Reforming Germany's risk structure equalization scheme - taking stock at the halfway point. Journal of Public Health 2005, 13(5):248-256.
3. Göpffarth D., Henke K.-D. The German central health fund - recent developments in health care financing in Germany. Health Policy 2013, 109(3):246-252.
4. Lisac M., Reimers L., Henke K.-D., Schlette S. Access and choice - competition under the roof of solidarity in German health care: an analysis of health policy reforms since 2004. Health Economics, Policy and Law 2010, 5:31-52.
5. Busse R, Blümel M, Ognyanova D. Germany: health system review. Health Systems in Transition, forthcoming.
6. Buchner F., Wasem J. Needs for further improvement: risk adjustment in the German health insurance system. Health Policy 2003, 77(1):21-35.
7. Knaus T., Nuscheler R. Risk selection in the German public health insurance system. Health Economics 2005, 14(12):1253-1271.
8. van de Ven W.P., Beck K., Van de Voorde C., Wasem J., Zmora I. Risk adjustment and risk selection in Europe: 6 years later. Health Policy 2007, 83:162-179.
9. Höppner K., Gress S., Rothgang H., Wasem J. Instrumente der Risikoselektion - Theorie und Empirie, in Jahrbuch Risikostrukturausgleich 2006. 10 Jahre Kassenwahlfreiheit 2006, 119-144. Asgard-Verlag Dr. Werner Hippe GmbH, Sankt Augustin. D. Göpffarth, S. Gress, K. Jacobs, J. Wasem (Eds.).
10. Götze R., Cacace M., Rothgang H. Von der Risiko- zur Anbieterselektion. Eigendynamiken wettbewerblicher Reformen in Gesundheitssystemen des Sozialversicherungstyps. Zeitschrift für Sozialreform 2009, 55(2):149-175.
11. Busse R. Disease management programs in Germany's statutory health insurance system. Health Affairs 2003, 23:56-67.
12. van de Ven W.P.M.M., Ellis R.P. Risk adjustment in competitive health plan markets. Handbook of health economics 2000, 755-845. Elsevier, Amsterdam. A.J. Culyer, J.P. Newhouse (Eds.).
13. Busse R, Drösler S, Glaeske G, Greiner W, Schäfer T, Schrappe M. Wissenschaftliches Gutachen für die Auswahl von 50 bis 80 Erkrankungen zur Berücksichtigung im morbiditätsorientierten Risikostrukturausgleich. Bonn; 2007.
14. Ash A.S., Ellis R.P., Pope G.C., Ayanian J.Z., Bates D.W., Birstin H., et al. Using diagnoses to describe populations and predict costs. Health Care Financing Review 2000, 21(3):7-28.
15. Reschke P., Sehlen S., Schiffhorst G., Schräder W.F., Lauterbach K.W., Wasem J. Klassifikationsmodelle für Versicherte im Risikostrukturausgleich. Bundesministerium für Gesundheit und Soziale Sicherung, Referat Information 2005, Publikation, Redaktion, Bonn.
16. Zhao Y., Ellis R.P., Ash A.S., Calabrese D., Ayanian J.Z., Slaughter J.P., et al. Measuring population health risks using inpatient diagnoses and outpatient pharmacy data. Health Service Research 2001, 36:180-193.
17. Drösler S, Hasford J, Kurth B-M, Schaefer M, Wasem J, Wille E. Evaluationsbericht zum Jahresbericht 2009 im Risikostrukturausgleich; 2011. http://www.bmg.bund.de/morbi-rsa.
18. Van Vliet, R.C.J.A., Everhardt, T.P., Van Asselt, M.M., Mazzola, G.J., Goudriaan, R., Notenboom, A. Overall toets risicovereveningsmodell somatische zorg 2011: Eindrapportage (WOR 530), Den Haag; 2010.
19. Van Vliet R.C.J.A. Predictability of individual health care expenditures. Journal of Risk and Insurance 1992, 59:443-461.
20. Cummings RB, Knutson D, Cameron BA, Derrick B. A comparative analysis of claims-based methods of health risk assessment for commercial populations; 2002. http://www.symmetry-health.com/SOAStudy.pdf.
21. Felder S. Gesundheitsfonds und Preiswettbewerb. Jahrbuch Risikostrukturausgleich 2007 2007, 215-230. Gesundheitsfonds, Asgard Verlag, Sankt Augustin. D. Göpffarth, S. Gress, K. Jacobs, J. Wasem (Eds.).
22. Schokkaert P, Beck K, Shmueli A, van de Ven W, van de Voorde C, Wasem J. Acceptable costs and risk adjustment: policy choices and ethical trade-offs. November 2006.
23. Bundesversicherungsamt. Erläuterungen zur Festlegung von Morbiditätsgruppen, Zuordnungsalgorithmus, Regressionsverfahren und Berechnungsverfahren durch das Bundesversicherungsamt; 2008.
24. van de Ven W.P., van Vliet R.C., van Barneveld E.M., Lamers L.M. Risk-adjusted capitation: recent experiences in the Netherlands. Health Affairs 1994, 13(Winter):120-136.